Literature DB >> 7637100

Age-related changes in resistive index following extracorporeal shock wave lithotripsy.

R Knapp1, F Frauscher, G Helweg, D zur Nedden, H Strasser, G Janetschek, G Bartsch.   

Abstract

PURPOSE: Changes in intrarenal vascular resistance after extracorporeal shock wave lithotripsy (ESWL*) were studied with Doppler ultrasound techniques.
MATERIALS AND METHODS: In 76 patients the resistive index was measured at an interlobar artery before and after ESWL in the treated and contralateral kidneys. The resistive index levels were compared to N-acetyl-beta-D-glucosaminidase levels in 40 patients.
RESULTS: We found an age-related positive linear correlation between post-therapeutic resistive index increases and patient age. N-acetyl-beta-D-glucosaminidase levels were also elevated after ESWL but these elevations were not age-related.
CONCLUSIONS: Elderly patients have a higher risk of post-ESWL renal tissue damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637100

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  The acute and long-term adverse effects of shock wave lithotripsy.

Authors:  James A McAteer; Andrew P Evan
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

2.  Effect of SWL on renal hemodynamics: could a change in renal artery contraction-relaxation responses be the cause?

Authors:  Erdal Yilmaz; Cagatay Mert; Zuhal Keskil; Devrim Tuglu; Ertan Batislam
Journal:  Urol Res       Date:  2012-09-04

3.  Reversible acute renal failure after unilateral extracorporeal shock-wave lithotripsy.

Authors:  Giovanni Liguori; Carlo Trombetta; Stefano Bucci; Leonardo Salamè; Silvana Savoldi; Emanuele Belgrano
Journal:  Urol Res       Date:  2003-10-01

4.  Evaluation of selected Doppler parameters of renal blood flow in patients undergoing extracorporeal shock wave lithotripsy.

Authors:  Krzysztof Balawender; Stanisław Orkisz
Journal:  Cent European J Urol       Date:  2017-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.